Update on pathological features of polyomavirus allograft nephropathy

Cinthia B. Drachenberg, Raghava B. Munivenkatappa, John C. Papadimitriou

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: The availability of potent immunosuppressant drugs has resulted in an increasing incidence of viral infections in solid organ transplantation. Of particular interest is the occurrence of polyomavirus allograft nephropathy. This affects 5-10% of kidney transplant recipients and is associated with a high risk of premature graft loss. RECENT FINDINGS: Histologically proven polyomavirus allograft nephropathy is preceded by a period of asymptomatic viruria and the eventual development of viremia. Systematic determinations of viruria and viremia have demonstrated that although polyomavirus infections are quite common in the first months following transplantation, only a minority of patients develop full blown polyomavirus allograft nephropathy. Progression of the condition leads to end-stage renal disease characterized by tubular atrophy, interstitial fibrosis and chronic inflammation. Early on, renal involvement is focal and liable to tissue sampling errors (false negative biopsy). Interpretation of the renal biopsy in the context of the viral loads (viruria, viremia), however, allows for early diagnosis even if the biopsy fails to demonstrate the viral cytopathic changes. SUMMARY: Recognition of the sequence of events leading to polyomavirus allograft nephropathy (viruria-viremia-nephritis) has provided the rational basis for screening protocols to identify patients at risk. Reduction of immunosuppression before irreversible renal scarring develops has resulted in a marked decrease in graft loss due to polyomavirus allograft nephropathy.

Original languageEnglish (US)
Pages (from-to)277-282
Number of pages6
JournalCurrent Opinion in Organ Transplantation
Volume11
Issue number3
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Polyomavirus
Viremia
Allografts
Kidney
Biopsy
Polyomavirus Infections
Transplants
Selection Bias
Nephritis
Organ Transplantation
Virus Diseases
Immunosuppressive Agents
Viral Load
Immunosuppression
Chronic Kidney Failure
Atrophy
Cicatrix
Early Diagnosis
Fibrosis
Transplantation

Keywords

  • BK
  • Decoy cells
  • JC
  • Polyomavirus
  • Renal biopsy
  • Viral loads
  • Viremia
  • Viruria

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Update on pathological features of polyomavirus allograft nephropathy. / Drachenberg, Cinthia B.; Munivenkatappa, Raghava B.; Papadimitriou, John C.

In: Current Opinion in Organ Transplantation, Vol. 11, No. 3, 06.2006, p. 277-282.

Research output: Contribution to journalArticle

Drachenberg, Cinthia B. ; Munivenkatappa, Raghava B. ; Papadimitriou, John C. / Update on pathological features of polyomavirus allograft nephropathy. In: Current Opinion in Organ Transplantation. 2006 ; Vol. 11, No. 3. pp. 277-282.
@article{9f11d73c88f648ebaf0c5b8d5213613e,
title = "Update on pathological features of polyomavirus allograft nephropathy",
abstract = "PURPOSE OF REVIEW: The availability of potent immunosuppressant drugs has resulted in an increasing incidence of viral infections in solid organ transplantation. Of particular interest is the occurrence of polyomavirus allograft nephropathy. This affects 5-10{\%} of kidney transplant recipients and is associated with a high risk of premature graft loss. RECENT FINDINGS: Histologically proven polyomavirus allograft nephropathy is preceded by a period of asymptomatic viruria and the eventual development of viremia. Systematic determinations of viruria and viremia have demonstrated that although polyomavirus infections are quite common in the first months following transplantation, only a minority of patients develop full blown polyomavirus allograft nephropathy. Progression of the condition leads to end-stage renal disease characterized by tubular atrophy, interstitial fibrosis and chronic inflammation. Early on, renal involvement is focal and liable to tissue sampling errors (false negative biopsy). Interpretation of the renal biopsy in the context of the viral loads (viruria, viremia), however, allows for early diagnosis even if the biopsy fails to demonstrate the viral cytopathic changes. SUMMARY: Recognition of the sequence of events leading to polyomavirus allograft nephropathy (viruria-viremia-nephritis) has provided the rational basis for screening protocols to identify patients at risk. Reduction of immunosuppression before irreversible renal scarring develops has resulted in a marked decrease in graft loss due to polyomavirus allograft nephropathy.",
keywords = "BK, Decoy cells, JC, Polyomavirus, Renal biopsy, Viral loads, Viremia, Viruria",
author = "Drachenberg, {Cinthia B.} and Munivenkatappa, {Raghava B.} and Papadimitriou, {John C.}",
year = "2006",
month = "6",
doi = "10.1097/01.mot.0000227846.21829.3d",
language = "English (US)",
volume = "11",
pages = "277--282",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Update on pathological features of polyomavirus allograft nephropathy

AU - Drachenberg, Cinthia B.

AU - Munivenkatappa, Raghava B.

AU - Papadimitriou, John C.

PY - 2006/6

Y1 - 2006/6

N2 - PURPOSE OF REVIEW: The availability of potent immunosuppressant drugs has resulted in an increasing incidence of viral infections in solid organ transplantation. Of particular interest is the occurrence of polyomavirus allograft nephropathy. This affects 5-10% of kidney transplant recipients and is associated with a high risk of premature graft loss. RECENT FINDINGS: Histologically proven polyomavirus allograft nephropathy is preceded by a period of asymptomatic viruria and the eventual development of viremia. Systematic determinations of viruria and viremia have demonstrated that although polyomavirus infections are quite common in the first months following transplantation, only a minority of patients develop full blown polyomavirus allograft nephropathy. Progression of the condition leads to end-stage renal disease characterized by tubular atrophy, interstitial fibrosis and chronic inflammation. Early on, renal involvement is focal and liable to tissue sampling errors (false negative biopsy). Interpretation of the renal biopsy in the context of the viral loads (viruria, viremia), however, allows for early diagnosis even if the biopsy fails to demonstrate the viral cytopathic changes. SUMMARY: Recognition of the sequence of events leading to polyomavirus allograft nephropathy (viruria-viremia-nephritis) has provided the rational basis for screening protocols to identify patients at risk. Reduction of immunosuppression before irreversible renal scarring develops has resulted in a marked decrease in graft loss due to polyomavirus allograft nephropathy.

AB - PURPOSE OF REVIEW: The availability of potent immunosuppressant drugs has resulted in an increasing incidence of viral infections in solid organ transplantation. Of particular interest is the occurrence of polyomavirus allograft nephropathy. This affects 5-10% of kidney transplant recipients and is associated with a high risk of premature graft loss. RECENT FINDINGS: Histologically proven polyomavirus allograft nephropathy is preceded by a period of asymptomatic viruria and the eventual development of viremia. Systematic determinations of viruria and viremia have demonstrated that although polyomavirus infections are quite common in the first months following transplantation, only a minority of patients develop full blown polyomavirus allograft nephropathy. Progression of the condition leads to end-stage renal disease characterized by tubular atrophy, interstitial fibrosis and chronic inflammation. Early on, renal involvement is focal and liable to tissue sampling errors (false negative biopsy). Interpretation of the renal biopsy in the context of the viral loads (viruria, viremia), however, allows for early diagnosis even if the biopsy fails to demonstrate the viral cytopathic changes. SUMMARY: Recognition of the sequence of events leading to polyomavirus allograft nephropathy (viruria-viremia-nephritis) has provided the rational basis for screening protocols to identify patients at risk. Reduction of immunosuppression before irreversible renal scarring develops has resulted in a marked decrease in graft loss due to polyomavirus allograft nephropathy.

KW - BK

KW - Decoy cells

KW - JC

KW - Polyomavirus

KW - Renal biopsy

KW - Viral loads

KW - Viremia

KW - Viruria

UR - http://www.scopus.com/inward/record.url?scp=33744462071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744462071&partnerID=8YFLogxK

U2 - 10.1097/01.mot.0000227846.21829.3d

DO - 10.1097/01.mot.0000227846.21829.3d

M3 - Article

AN - SCOPUS:33744462071

VL - 11

SP - 277

EP - 282

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -